Baxter International Inc., a leader in healthcare products, demonstrates a stable yet cautious outlook for investors. Despite facing challenges in ROE and other financial metrics, the company continues to expand through its diverse healthcare offerings worldwide. Cautious investors may consider this stock for its long-term potential.
Baxter's current fundamental rating indicates room for improvement with particular challenges in return and equity metrics.
| Category | Score | Visualization |
|---|---|---|
| Overall Score | 2 | |
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
The historical rating shows consistency in Baxter's financial performance over recent periods.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-09 | 2 | 4 | 1 | 1 | 1 | 1 | 2 |
| 2025-06-09 | 2 | 4 | 1 | 1 | 1 | 1 | 2 |
Analysts remain neutral with price targets emphasizing a hold, ensuring stabilized expectations.
| High | Low | Median | Consensus |
|---|---|---|---|
| 42 | 42 | 42 | 42 |
Analysts exhibit a cautious outlook with a majority recommending to hold.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 18 | |
| Sell | 1 | |
| Strong Sell | 0 |
Baxter International Inc. presents a mixed investment opportunity with stable aspects in cash flow contrasted by lower performance in equity-based metrics. While the analyst consensus indicates a hold, the company's innovative healthcare solutions and global presence offer long-term growth potential. Investors should weigh these factors before making investment decisions. The company’s historical rating consistency may appeal to those preferring risk-adjusted strategies. Ultimately, it is a stock with both risks and room for growth contingent on effective management and market conditions.